Search for: "Genzyme Corporation" Results 41 - 60 of 71
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jul 2011, 2:09 pm
The idea of having a drug company planting human interest stories in the press is yucky ...a big corporation pulling string behind the scenes. [read post]
21 Dec 2010, 11:00 am by FDABlog HPM
  The Sandoz petition follows another citizen petition, submitted on behalf of Genzyme Corporation (“Genzyme”), concerning the Agency’s ability to approve Cobrek’s pending ANDA No. 90-040 for Doxercalciferol Injection. [read post]
2 Aug 2009, 3:13 pm
., Anaheim, CA Corporate Counsel – Google Legal, Mountain View, CA Corporate Counsel – Genzyme, Cambridge, MA Assistant General Counsel – Standard & Poor’s, New York, NY Associate General Counsel – Progress Energy Service Company, LLC (PESC) , Raleigh, NC Assistant General Counsel – JPMorgan Chase , Columbus, OH Counsel – Disney, Burbank, CA Senior Corporate Counsel - Human Resources… [read post]
13 Feb 2019, 7:44 am
The two plaintiffs are Genzyme Corporation (holder of  supplementary protection certificate No C00716606/01), and  its  licensee, Sanofi-Aventis (holder of the authorizations for the products Renagel and Renvela). [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/14: Daiichi Sankyo Inc.and Genzyme Corporation v. [read post]
19 May 2009, 5:04 am
Cutting to the heart of the federal court’s analysis, the district court held that under Second Circuit authority “‘a corporation is not required to disclose a fact merely because a reasonable investor would very much like to know that fact. [read post]
29 Dec 2009, 9:09 pm by ipdeals
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi Sankyo Tim… [read post]
29 Dec 2009, 9:09 pm by ipdeals
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi Sankyo Tim… [read post]
10 Jul 2015, 11:46 am by Greene LLP
Those companies were later narrowed down to just four, AstraZeneca, Cephalon, Biogen and Genzyme Corporation. [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
The request concerned HHS to grant to open license to certain patents owned by Mount Sinai School of Health that were funded by NIH (and exclusively licensed by Mount Sinai to Genzyme Corporation) to permit manufacturing of Fabrazyme®. [read post]
10 Aug 2015, 5:10 pm by Kevin LaCroix
Gillon Alexander Hardiman One of the most distinctive corporate and securities litigation phenomena over the last several years has been the rise in merger objection lawsuits. [read post]
20 Aug 2010, 5:00 am by J Robert Brown Jr.
  Thus, the board at Genzyme recently induced Carl Icahn to forego a proxy contest. [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter &… [read post]
11 Nov 2010, 2:32 pm by Kara OBrien
Hostile Activity: Pat Vlahakis says there is a slight uptick in unsolicited and hostile deals including Airgas and Genzyme. [read post]
15 Mar 2016, 5:09 pm by Kevin LaCroix
  Background   The multiple sclerosis drug Lemtrada was developed and owned by defendant Genzyme Corporation and, following a 2011 acquisition, Sanofi. [read post]
20 Jan 2010, 10:36 am by Ted Allen
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]